SEC 13F Intelligence

Waters Parkerson & Co., LLC / DC4

Waters Parkerson & Co., LLC’s Dexcom Inc Position

Does Waters Parkerson & Co., LLC own Dexcom Inc (DC4)? Not currently — the last reported position was 354.5K shares worth $24M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$24M
Q3 2025
Shares
354.5K
% of Portfolio
+1.16%
Quarters Held
9
position exited

Position History DC4

Reported value by quarter
Q3 ’23: $21,151Q3 ’23Q4 ’23: $32,050Q1 ’24: $36,305Q1 ’24Q2 ’24: $30,912Q3 ’24: $20,704Q3 ’24Q4 ’24: $24MQ1 ’25: $23MQ1 ’25Q2 ’25: $31MQ3 ’25: $24MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025354.5K$24M+1.16%
Q2 2025351.3K$31M+1.53%
Q1 2025337.6K$23M+1.23%
Q4 2024313.2K$24M+1.28%
Q3 2024308.8K$20,704+1.05%
Q2 2024272.6K$30,912+1.65%
Q1 2024261.7K$36,305+1.86%
Q4 2023258.3K$32,050+1.77%
Q3 2023226.7K$21,151+1.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Waters Parkerson & Co., LLC’s full portfolio or all institutional holders of DC4.